Gemini
Ended Awarded
- Contract number
- HHSN26100012
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,250
Award facts
- Contract value
-
- $19,250.00 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6850 Miscellaneous Chemical Specialties
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 0 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Broderick, CA 95605, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100012?
HHSN26100012 was awarded to Gemini Bioproducts LLC by National Cancer Institute (National Institutes of Health) on February 24, 2010.
How much is contract HHSN26100012 worth?
The government has obligated $19,250 on HHSN26100012.
Is contract HHSN26100012 an order under another contract?
Yes. HHSN26100012 is a BPA call under HHSN263199700048255B, a blanket purchase agreement.
Was contract HHSN26100012 competed?
The extent of competition for HHSN26100012 was competed under sap. The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award